methylene blue has been researched along with Disease Exacerbation in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 7 (43.75) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Bartochowski, Z; Grossberg, GT; Hashweh, NN; Khoury, R | 1 |
| Baddeley, TC; Bentham, P; Bracoud, L; Ganesan, H; Gauthier, S; Hammel, J; Hardlund, J; Harrington, CR; Jia, J; Kipps, CM; Kook, K; Moebius, HJ; Murray, AD; Riedel, G; Rubino, CM; Schelter, BO; Shiells, H; Staff, RT; Storey, JMD; Vuksanovic, V; Wischik, CM; Wischik, DJ | 1 |
| Guo, H; Jiang, HM; Jiang, Q; Li, JW; Lv, ZY; Shi, DQ; Sun, KY; Sun, ZY; Wang, RL; Wu, R; Xu, J; Xu, XQ | 1 |
| Évora, PRB; Faria, FM; Farina, JA; Oliveira, CC; Rosique, MJ; Rosique, RG | 1 |
| Weinstein, JD | 1 |
| Deppe, H; Kesting, M; Mücke, T; Sculean, A; Wagenpfeil, S | 1 |
| Duong, TQ; Huang, S; Jiang, Z; Rodriguez, P; Shen, Q | 1 |
| Gravitz, L | 1 |
| Lougheed, R; Turnbull, J | 1 |
| Dibaj, P; Göricke, B; Hanisch, UK; Kirchhoff, F; Le Meur, K; Neusch, C; Scheffel, J; Schomburg, ED; Steffens, H; Weishaupt, JH; Zschüntzsch, J | 1 |
| Allescher, HD; Classen, M; Egger, K; Höfler, H; Meining, A; Ott, R; Rösch, T; Werner, M | 1 |
| Albo, C; Alvarez-Larrán, A; Campos, A; Cid, J; Del Río, J; Muncunill, J; Peña, F; Pereira, A; Ramírez, C; Sanz, C; Sastre, JL | 1 |
| Ishikura, H; Koda, K; Kosugi, C; Miyazaki, M; Nishimura, M; Oda, K; Seike, K; Shimizu, K; Shioiri, M; Takano, S | 1 |
| da Costa-Pereira, A; Dinis-Ribeiro, M; Lopes, C; Moreira-Dias, L | 1 |
| Bashir, A; Burstein, D; Gray, ML; Hartke, J | 1 |
| Fallon, MB | 1 |
2 review(s) available for methylene blue and Disease Exacerbation
| Article | Year |
|---|---|
An evaluation of hydromethylthionine as a treatment option for Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cognitive Dysfunction; Cohort Studies; Disease Progression; Dose-Response Relationship, Drug; Humans; Methylene Blue; Protein Aggregates; Randomized Controlled Trials as Topic; tau Proteins; Treatment Outcome | 2020 |
Methylene blue-photoinactivated plasma vs. fresh-frozen plasma as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura.
Topics: Adult; Aged; Aged, 80 and over; Disease Progression; Female; Humans; Male; Methylene Blue; Middle Aged; Photochemistry; Plasma; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic; Recurrence; Remission Induction; Retrospective Studies; Survival Analysis; Treatment Outcome; Virus Inactivation | 2004 |
1 trial(s) available for methylene blue and Disease Exacerbation
| Article | Year |
|---|---|
Concentration-Dependent Activity of Hydromethylthionine on Clinical Decline and Brain Atrophy in a Randomized Controlled Trial in Behavioral Variant Frontotemporal Dementia.
Topics: Adult; Aged; Atrophy; Brain; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Frontotemporal Dementia; Humans; Magnetic Resonance Imaging; Male; Methylene Blue; Middle Aged; Treatment Outcome | 2020 |
13 other study(ies) available for methylene blue and Disease Exacerbation
| Article | Year |
|---|---|
Methylene blue prevents osteoarthritis progression and relieves pain in rats via upregulation of Nrf2/PRDX1.
Topics: Animals; Arthralgia; Blotting, Western; Disease Progression; Humans; Male; Methylene Blue; NF-E2-Related Factor 2; Osteoarthritis; Peroxiredoxins; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Stifle; Up-Regulation; X-Ray Microtomography | 2022 |
Methylene blue reduces progression of burn and increases skin survival in an experimental rat model.
Topics: Animals; Antioxidants; Burns; Disease Models, Animal; Disease Progression; Injections, Intraperitoneal; Male; Malondialdehyde; Methylene Blue; Necrosis; Nitric Oxide; Oxidative Stress; Rats; Rats, Wistar; Skin; Wound Healing | 2017 |
A unique and promising combination of medications for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Brain; Dementia; Disease Progression; Drug Design; Drug Therapy, Combination; Humans; Inflammation; Methylene Blue; Neurons; Nicergoline; Oxidative Stress; Pentoxifylline; Pyridoxamine; Pyrimidines | 2017 |
Nonsurgical antimicrobial photodynamic therapy in moderate vs severe peri-implant defects: a clinical pilot study.
Topics: Alveolar Bone Loss; Alveolar Process; Dental Implants; Disease Progression; Follow-Up Studies; Gingival Recession; Humans; Low-Level Light Therapy; Methylene Blue; Peri-Implantitis; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Phenothiazines; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Radiography; Treatment Outcome | 2013 |
Methylene blue treatment delays progression of perfusion-diffusion mismatch to infarct in permanent ischemic stroke.
Topics: Animals; Brain; Brain Ischemia; Cerebrovascular Circulation; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Infarction, Middle Cerebral Artery; Magnetic Resonance Imaging; Male; Methylene Blue; Neuroprotective Agents; Random Allocation; Rats, Sprague-Dawley; Treatment Outcome | 2014 |
Drugs: a tangled web of targets.
Topics: Alanine; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azepines; Clinical Trials as Topic; Disease Progression; Genetic Therapy; Glycogen Synthase Kinase 3; Humans; Indoles; Memantine; Methylene Blue; Molecular Targeted Therapy; Nerve Growth Factor; Neurofibrillary Tangles; Phosphorylation; tau Proteins | 2011 |
Lack of effect of methylene blue in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Disease Models, Animal; Disease Progression; Female; Male; Methylene Blue; Mice; Mice, Congenic; Superoxide Dismutase; Superoxide Dismutase-1; Survival Analysis; Treatment Outcome | 2011 |
Influence of methylene blue on microglia-induced inflammation and motor neuron degeneration in the SOD1(G93A) model for ALS.
Topics: Amyotrophic Lateral Sclerosis; Animals; Animals, Genetically Modified; Cell Survival; Cytokines; Disease Models, Animal; Disease Progression; Female; Inflammation; Male; Methylene Blue; Mice; Microglia; Motor Activity; Motor Neurons; Superoxide Dismutase; Superoxide Dismutase-1; Time Factors | 2012 |
Biopsy surveillance is still necessary in patients with Barrett's oesophagus despite new endoscopic imaging techniques.
Topics: Adenocarcinoma; Adult; Aged; Barrett Esophagus; Biopsy; Chi-Square Distribution; Coloring Agents; Disease Progression; Esophageal Neoplasms; Esophagoscopy; Esophagus; Female; Humans; Male; Methylene Blue; Middle Aged; Precancerous Conditions; Predictive Value of Tests; Sensitivity and Specificity; Video Recording | 2003 |
Assessment of rectal aberrant crypt foci by standard chromoscopy and its predictive value for colonic advanced neoplasms.
Topics: Adult; Aged; Aged, 80 and over; Colonic Neoplasms; Colonoscopy; Coloring Agents; Disease Progression; Female; Humans; Intestinal Mucosa; Logistic Models; Male; Methylene Blue; Middle Aged; Precancerous Conditions; Predictive Value of Tests; Rectum | 2006 |
Feasibility and cost-effectiveness of using magnification chromoendoscopy and pepsinogen serum levels for the follow-up of patients with atrophic chronic gastritis and intestinal metaplasia.
Topics: Adult; Aged; Chronic Disease; Cost-Benefit Analysis; Decision Trees; Disease Progression; Endoscopy, Gastrointestinal; Feasibility Studies; Female; Follow-Up Studies; Gastric Mucosa; Gastritis, Atrophic; Humans; Male; Markov Chains; Metaplasia; Methylene Blue; Middle Aged; Pepsinogens; Precancerous Conditions; Prognosis; Quality-Adjusted Life Years; Risk Assessment; Survival Rate | 2007 |
Nondestructive imaging of human cartilage glycosaminoglycan concentration by MRI.
Topics: Animals; Arthroplasty, Replacement, Knee; Cartilage, Articular; Cattle; Coloring Agents; Contrast Media; Disease Progression; Feasibility Studies; Gadolinium DTPA; Glycosaminoglycans; Humans; Knee Joint; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Methylene Blue; Reproducibility of Results; Sodium | 1999 |
Methylene blue and cirrhosis: pathophysiologic insights, therapeutic dilemmas.
Topics: Disease Progression; Enzyme Inhibitors; Guanylate Cyclase; Hepatopulmonary Syndrome; Humans; Liver Cirrhosis; Methylene Blue; Nitric Oxide | 2000 |